Silymarin
J01 - Antibacterials for systemic use
Unknown
Prodrug
First-in-class
Orphan
JFDA label: Cirkulin Liver Protection (Sylmarin)
Chemistry & Properties
| Formula | C25H22O10 |
| Molecular weight | 482.4 g/mol |
| IUPAC name | 3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one |
| CAS | 65666-07-1 |
| PubChem CID | 5213 |
| InChIKey | SEBFKMXJBCUCAI-UHFFFAOYSA-N |
| logP | 2.4 (XLogP 2.4) |
| Polar surface area | 155.0 Ų |
| H-bond acceptors / donors | 10 / 5 |
SMILES
COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O
Biology & Pharmacokinetics
Pharmacokinetics predicted
| Bioavailability | 70.0% |
| Half-life | 1.878 h |
| Volume of distribution | 1.286 L/kg |
| Protein binding | 95.3% |
| BBB penetrant | No |
Enzyme interactions
| Enzyme | Role | Detail |
| CYP2C8 | Inhibitor |
— |
| CYP2C9 | Substrate |
— |
| CYP3A4 | Inhibitor |
— |
Transporters
BCRP (Inhibitor)BCRP (Inhibitor)BSEP (Inhibitor)MDR1 (Inhibitor)MRP1 (Inhibitor)MRP1 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)OATP2B1 (Inhibitor)P-gp (Inhibitor)P-gp (Substrate)
Registered Products (1)
| Brand | Form / strength | Pack | Agent | Citizen (JOD) |
| Cirkulin Liver Protection (Sylmarin)
|
Tablet 85 mg |
60 tab |
AL THARAA FOR PHARMACEUTICALS AND MEDICINE TRADING CO(BEIT LEHEM DRUG STORE)) |
12.720 |